Literature DB >> 30593085

External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.

Kazuma Yamakawa1, Jumpei Yoshimura1, Takashi Ito2, Mineji Hayakawa3, Toshimitsu Hamasaki4, Satoshi Fujimi1.   

Abstract

BACKGROUND: Two different criteria for evaluating coagulopathy in sepsis were recently released: sepsis-induced coagulopathy (SIC) and sepsis-associated coagulopathy (SAC). Although both use universal haemostatic markers of platelet count and pro-thrombin time, significance and usefulness of these criteria remain unclear.
OBJECTIVE: This article validates and evaluates the significance of SIC and SAC criteria compared with the International Society on Thrombosis and Haemostasis (ISTH) overt disseminated intravascular coagulation (DIC) and Japanese Association for Acute Medicine (JAAM) DIC criteria.
METHODS: Clinical characteristics of patients from a nationwide Japanese cohort were classified by SIC, SAC or DIC status and relations between criteria were examined. We evaluated associations between in-hospital mortality and anticoagulant therapy according to the SIC, SAC or DIC status to clarify the significance of criteria for introducing anticoagulants. Intervention effects were analysed by Cox regression analysis adjusted by propensity scoring.
RESULTS: Incidences of coagulopathy diagnosed by SIC and JAAM DIC were similar, whereas those of SAC and ISTH overt DIC were about half of the former two (61.4%, 60.8% vs. 45.3%, 29.3%). Severity and mortality of all criteria were almost comparable. For validating initiation of anticoagulation, favourable effects of anticoagulant therapy were observed only in sub-sets with, and not without, coagulopathy diagnosed by all four criteria. Slight non-significant differences between anticoagulant groupings were found in ISTH overt DIC- and SAC-negative populations, suggesting that some patients even 'without' these criteria may benefit from anticoagulant therapy.
CONCLUSION: Newly developed SIC diagnostic criteria for coagulopathy may be valuable in detecting appropriate candidates for anticoagulant therapy in sepsis and a useful alternative to conventional DIC scoring systems. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30593085     DOI: 10.1055/s-0038-1676610

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  [Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].

Authors:  H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-03-14

2.  Flow Cytometry-Based Quantification of Neutrophil Extracellular Traps Shows an Association with Hypercoagulation in Septic Shock and Hypocoagulation in Postsurgical Systemic Inflammation-A Proof-of-Concept Study.

Authors:  Emmanuel Schneck; Franziska Mallek; Julia Schiederich; Emil Kramer; Melanie Markmann; Matthias Hecker; Natascha Sommer; Norbert Weissmann; Oleg Pak; Gabriela Michel; Andreas Hecker; Winfried Padberg; Andreas Boening; Michael Sander; Christian Koch
Journal:  J Clin Med       Date:  2020-01-08       Impact factor: 4.241

3.  Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19.

Authors:  Ying X Gue; Maria Tennyson; Jovia Gao; Shuhui Ren; Rahim Kanji; Diana A Gorog
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

4.  Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan.

Authors:  Chie Tanaka; Takashi Tagami; Saori Kudo; Akiko Takehara; Reo Fukuda; Fumihiko Nakayama; Junya Kaneko; Yoshito Ishiki; Shin Sato; Masamune Kuno; Kyoko Unemoto
Journal:  Int J Hematol       Date:  2021-04-24       Impact factor: 2.490

5.  Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis.

Authors:  Lonneke A van Vught; Fabrice Uhel; Chao Ding; Cees Van't Veer; Brendon P Scicluna; Hessel Peters-Sengers; Peter M C Klein Klouwenberg; Peter Nürnberg; Olaf L Cremer; Marcus J Schultz; Tom van der Poll
Journal:  J Thromb Haemost       Date:  2021-02-17       Impact factor: 5.824

6.  A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure.

Authors:  Yiyang Tang; Qin Chen; Benhui Liang; Baohua Peng; Meijuan Wang; Jing Sun; Zhenghui Liu; Lihuang Zha; Zaixin Yu
Journal:  Front Cardiovasc Med       Date:  2022-09-16

7.  [Progress in quantitative diagnosis of sepsis-induced disseminated intravascular coagulation].

Authors:  L L Luo; H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

Review 8.  Recent advances in the research and management of sepsis-associated DIC.

Authors:  Toshiaki Iba; Jean Marie Connors; Isao Nagaoka; Jerrold H Levy
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

9.  The Value of Thromboelastography in the Diagnosis of Sepsis-Induced Coagulopathy.

Authors:  Cuizhu Luo; Hongbin Hu; Jian Gong; Yun Zhou; Zhongqing Chen; Shumin Cai
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 10.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.